Pharma's Almanac | Cell and Gene Therapy (2)

240 Articles Available

2 10

Column: Regional

Expanding the Cell and Gene Therapy Ecosystem in Philadelphia

PAO-12-21-CL-05

Gene Therapy Analytics

Overcoming Analytical Challenges for Gene Therapies

PAO-02-022-CL-14

M&A

Ginkgo Bioworks Signs Definitive Agreement to Acquire FGen AG, a Leading Bioengineering Company and Its Proprietary Ultra-High-Throughput Screening Platform

PR-M03-22-05

Mesenchymal Stem Cells

Moving Beyond the Industrialization of MSCs

PAO-12-21-CL-06

New Capabilities

Discovery Life Sciences Streamlines Cell and Gene Therapy Manufacturing with Expanded Human Cellular Starting Materials

PR-M02-22-15

Mergers and Acquisitions

Integrating Services Across the Full Spectrum of Cell and Gene Therapy

PAO-02-22-R250-10

Gene Therapy

Changing Lives, One Patient at a Time

PAO-01-22-R250-16

Cell and Gene Therapy

Realizing the Promise of Cell and Gene Therapy with an Advanced Manufacturing Platform

PAO-01-22-R250-15

Consulting

Helping Biopharma Companies Grow with Insight

PAO-01-22-R250-17

Cell and Gene Therapy

Expanding the Philadelphia Cell and Gene Therapy Hub

PAO-01-22-R250-09

Vaccines

100 Years in Vaccines and Looking Toward the Future

PAO-01-22-R250-13

Immuno-oncology

Activating the Immune System to Treat Cancer

PAO-01-22-R250-06

Expansion

FDA Accepts GMP Plasmid DMF and Capacity Expansion Enabling Andelyn Biosciences to Offer Faster Gene Therapy Development

PR-M01-22-10

M&A

Analytical Service Leaders in Biopharmaceutical and Gene Therapy Development Unify Operations and Re-brand as ProtaGene

PR-M01-22-09

2021 Roundup: The Year of Cell and Gene Therapy

Cell and Gene Therapy

Cell and Gene Therapies’ Evolving Temperature-Controlled Requirements Call for Specialized Logistics Solutions

PAO-11-21-CL-11

Cell and Gene Therapy

It’s All Here – Talent. Research. Results.

PR-M11-21-01

Cell and Gene Therapy

Coping with a Talent Shortage and Talent War in Cell and Gene Therapy

PAO-10-21-CL-12

Cell and Gene Therapy

A Novel Approach to Drive Disruptive Innovation in Cell and Gene Therapy

PAO-10-21-CL-14

Gene Therapy

A Customer-Centric Approach to Cell and Gene Therapy Manufacturing

PAO-10-21-CL-06

Cell and Gene Therapy

Quality and Regulatory Challenges Surrounding New Cell and Gene Therapy Products

PAO-09-21-CL-07

Gene Editing

Prime Medicine Launches with $315 Million Financing to Deliver on the Promise of Prime Editing

PR-M07-21-04

Cancer Research

Inceptor Bio Launches Next-Generation CAR-T, CAR-M, and NK/NKT Platform Focused on Advancing Cell and Gene Therapies to Cure Difficult-To-Treat Cancers

PR-M06-21-018

Cell and Gene Therapy

6 Analytical Strategies to Consider Before Submitting Your Cell and Gene Therapy Application

PAO-06-21-CL-04

2 10

Cell and Gene Therapy (2)

240 Articles Available

Can't find what you're looking for? Try our advanced search.

Column: Regional

Expanding the Cell and Gene Therapy Ecosystem in Philadelphia

Gene Therapy Analytics

Overcoming Analytical Challenges for Gene Therapies

M&A

Ginkgo Bioworks Signs Definitive Agreement to Acquire FGen AG, a Leading Bioengineering Company and Its Proprietary Ultra-High-Throughput Screening Platform

Mesenchymal Stem Cells

Moving Beyond the Industrialization of MSCs

New Capabilities

Discovery Life Sciences Streamlines Cell and Gene Therapy Manufacturing with Expanded Human Cellular Starting Materials

Mergers and Acquisitions

Integrating Services Across the Full Spectrum of Cell and Gene Therapy

Gene Therapy

Changing Lives, One Patient at a Time

Cell and Gene Therapy

Realizing the Promise of Cell and Gene Therapy with an Advanced Manufacturing Platform

Consulting

Helping Biopharma Companies Grow with Insight

Cell and Gene Therapy

Expanding the Philadelphia Cell and Gene Therapy Hub

Vaccines

100 Years in Vaccines and Looking Toward the Future

Immuno-oncology

Activating the Immune System to Treat Cancer

Expansion

FDA Accepts GMP Plasmid DMF and Capacity Expansion Enabling Andelyn Biosciences to Offer Faster Gene Therapy Development

M&A

Analytical Service Leaders in Biopharmaceutical and Gene Therapy Development Unify Operations and Re-brand as ProtaGene

2021 Roundup: The Year of Cell and Gene Therapy

Cell and Gene Therapy

Cell and Gene Therapies’ Evolving Temperature-Controlled Requirements Call for Specialized Logistics Solutions

Cell and Gene Therapy

It’s All Here – Talent. Research. Results.

Cell and Gene Therapy

Coping with a Talent Shortage and Talent War in Cell and Gene Therapy

Cell and Gene Therapy

A Novel Approach to Drive Disruptive Innovation in Cell and Gene Therapy

Gene Therapy

A Customer-Centric Approach to Cell and Gene Therapy Manufacturing

Cell and Gene Therapy

Quality and Regulatory Challenges Surrounding New Cell and Gene Therapy Products

Gene Editing

Prime Medicine Launches with $315 Million Financing to Deliver on the Promise of Prime Editing

Cancer Research

Inceptor Bio Launches Next-Generation CAR-T, CAR-M, and NK/NKT Platform Focused on Advancing Cell and Gene Therapies to Cure Difficult-To-Treat Cancers

Cell and Gene Therapy

6 Analytical Strategies to Consider Before Submitting Your Cell and Gene Therapy Application